Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 222

The DOI matches its Crossref record.

Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability

Open access
Grover, Gary J., Mellström, Karin, Ye, Liu, Malm, Johan, Li, Yi-Lin, Bladh, Lars-Göran, Sleph, Paul G., Smith, Mark A., George, Rocco, Vennström, Björn, Mookhtiar, Kasim, Horvath, Ryan, Speelman, Jessica, Egan, Donald, Baxter, John D.·2003·Proceedings of the National Academy of Sciences

Abstract

Few treatments for obesity exist and, whereas efficacious therapeutics for hyperlipidemia are available, further improvements are desirable. Thyroid hormone receptors (TRs) regulate both body weight and cholesterol levels. However, thyroid hormones also have deleterious effects, particularly on the heart. The TRβ subtype is involved in cholesterol lowering and possibly elevating metabolic rate, whereas TRα appears to be more important for control of heart rate (HR). In the current studies, we examined the effect of TRβ activation on metabolic rate and HR with either TR α 1 – / – mice or the selective TRβ agonist KB-141 in mice, rats, and monkeys. 3,5,3′-triiodi- l -thyronine (T 3 ) had a greater effect on increasing HR in WT than in TR α – / – mice (ED 15 values of 34 and 469 nmol/kg/day, respectively). T 3 increased metabolic rate [whole body oxygen consumption (MV O 2 )] in both WT and TR α – / – mice, but the effect in the TR α 1 – / – mice at the highest dose was half that of the WT mice. Thus, stimulation of MV O 2 is likely due to both TRα and -β. T 3 had equivalent potency for cholesterol reduction in WT and TR α – / – mice. KB-141 increased MV O 2 with selectivities of 16.5- and 11.2-fold vs. HR in WT and TR α 1 – / – mice, respectively. KB-141 also increased MV O 2 with a 10-fold selectivity and lowered cholesterol with a 27-fold selectivity vs. HR in rats. In primates, KB-141 caused significant cholesterol, lipoprotein (a), and body-weight reduction (up to 7% after 1 wk) with no effect on HR. TRβ-selective agonists may constitute a previously uncharacterized class of drugs to treat obesity, hypercholesterolemia, and elevated lipoprotein (a).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1633737100

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 222

Metadata

Authors
Grover, G. J., Mellström, K., Ye, L., Malm, J., Li, Y.-L., Bladh, L.-G., Sleph, P. G., Smith, M. A., George, R., Vennström, B., Mookhtiar, K., Horvath, R., Speelman, J., Egan, D., & Baxter, J. D.
Venue
Proceedings of the National Academy of Sciences
Published
2003-07-29
Volume
100
Issue
17
Pages
10067-10072
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2141742236
Cited by
222
References
0
FWCI
10.51
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. https://app.cochat.ai/papers/10.1073/pnas.1633737100
The paper
Grover, G. J., Mellström, K., Ye, L., Malm, J., Li, Y.-L., Bladh, L.-G., Sleph, P. G., Smith, M. A., George, R., Vennström, B., Mookhtiar, K., Horvath, R., Speelman, J., Egan, D., & Baxter, J. D. (2003). Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1633737100

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.